This issue brief describes how four state Medicaid programs used reports developed by Oregon's Drug Effectiveness Review Project (DERP) to develop pharmacy policies, based on interviews with state officials, advocacy groups, clinicians, and other stakeholders. The DERP reports have filled a void for states seeking inexpensive systematic reviews of evidence on comparative effectiveness. The influence of DERP reports on state policy was significant in all states, but varied from being the most prominent clinical evidence used in development of a preferred drug list, to being one of many clinical references used to create provider education tools. Stakeholders expressed concerns that Medicaid programs consider a wide range of evidence to promote regionally sensitive policies, and that open processes are maintained to ensure accountability.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)